{"DataElement":{"publicId":"2730479","version":"1","preferredName":"Concomitant Agent Discontinue Reason","preferredDefinition":"Text term to identify the explantion for the discontinuation of a concomitant agent. [Manually-curated]","longName":"CONCOM_AGT_DC_RSN","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2730470","version":"1","preferredName":"Concomitant Agent Discontinue Reason","preferredDefinition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol._To stop or end, permanently or temporarily._An explanation of the cause of some phenomenon or action.","longName":"CONCOM_AGT_DC_RSN","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2715186","version":"1","preferredName":"Concomitant Agent","preferredDefinition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.","longName":"C70902","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Agent","conceptCode":"C70902","definition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol's complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41A63E7F-5495-4025-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-19","endDate":null,"createdBy":"UMLLOADER_BRIDG","dateCreated":"2007-12-19","modifiedBy":"ONEDATA","dateModified":"2007-12-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2730468","version":"1","preferredName":"Discontinued Reason","preferredDefinition":"Discontinued; stopped permanently or temporarily.:An explanation of the cause of some phenomenon or action.","longName":"C25484:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"469B2CAD-1375-0982-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"ONEDATA","dateModified":"2008-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"469B2CAD-1386-0982-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2730472","version":"1","preferredName":"Concomitant Agent Discontinue Reason","preferredDefinition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol._To stop or end, permanently or temporarily._An explanation of the cause of some phenomenon or action.","longName":"CONCOM_DC_RSN","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other (specify)","valueDescription":"Other specify","ValueMeaning":{"publicId":"2570538","version":"1","preferredName":"Other specify","longName":"2570538","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E097-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-11-17","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12 - reversed concept order to match the semantics of this phrase which is \"other\" with \"specify\" as a qualifier/modifier - DW 12-30-2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"469B471D-4EEA-0F14-E044-0003BA3F9857","beginDate":"2008-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"REEVESD","dateModified":"2008-02-20","deletedIndicator":"No"},{"value":"Change in therapy","valueDescription":"Change in therapy","ValueMeaning":{"publicId":"2730473","version":"1","preferredName":"Change in therapy","longName":"2730473","preferredDefinition":"Change in therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"469B471D-4EF6-0F14-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"469B471D-4F0F-0F14-E044-0003BA3F9857","beginDate":"2008-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"REEVESD","dateModified":"2008-02-20","deletedIndicator":"No"},{"value":"Refused","valueDescription":"PATIENT REFUSED","ValueMeaning":{"publicId":"2561131","version":"1","preferredName":"PATIENT REFUSED","longName":"2561131","preferredDefinition":"PATIENT REFUSED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BBD8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-05-08","endDate":null,"createdBy":"CVALMONT","dateCreated":"2002-05-08","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"469B471D-4F24-0F14-E044-0003BA3F9857","beginDate":"2008-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"REEVESD","dateModified":"2008-02-20","deletedIndicator":"No"},{"value":"Withdrew","valueDescription":"Patient withdrew","ValueMeaning":{"publicId":"2730474","version":"1","preferredName":"Patient withdrew","longName":"2730474","preferredDefinition":"Patient withdrew","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"469B471D-4F31-0F14-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"469B471D-4F4A-0F14-E044-0003BA3F9857","beginDate":"2008-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"REEVESD","dateModified":"2008-02-20","deletedIndicator":"No"},{"value":"Disease progression","valueDescription":"Disease Progression","ValueMeaning":{"publicId":"2561827","version":"1","preferredName":"Disease Progression","longName":"2561827","preferredDefinition":"Cancer that continues to grow or spread.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BE90-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"SOKKERL","dateModified":"2023-03-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"469B471D-4F56-0F14-E044-0003BA3F9857","beginDate":"2008-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"REEVESD","dateModified":"2008-02-20","deletedIndicator":"No"},{"value":"Completed","valueDescription":"Treatment completed","ValueMeaning":{"publicId":"2730475","version":"1","preferredName":"Treatment completed","longName":"2730475","preferredDefinition":"Treatment completed","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"469B471D-4F62-0F14-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"469B471D-4F7B-0F14-E044-0003BA3F9857","beginDate":"2008-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"REEVESD","dateModified":"2008-02-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2730471","version":"1","preferredName":"Concomitant Agent Discontinued Reason","preferredDefinition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.:Discontinued; stopped permanently or temporarily.:An explanation of the cause of some phenomenon or action.","longName":"C70902:C25484:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Agent","conceptCode":"C70902","definition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol's complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"469B2CAD-139C-0982-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"ONEDATA","dateModified":"2008-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"469B2CAD-13AD-0982-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"PWEST","dateModified":"2014-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812731","version":"1","longName":"U Washington","context":"NCIP"},{"publicId":"2812732","version":"1","longName":"FES Study","context":"NCIP"},{"publicId":"2812734","version":"1","longName":"U Washington New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Reason for Discontinuation","type":"Preferred Question Text","description":"Reason for Discontinuation","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"469B5316-9D07-1109-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":"Curated to support U Washington adoption of C3D for FES trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}